{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T11:37:03Z","timestamp":1778931423918,"version":"3.51.4"},"reference-count":24,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2004,2]]},"DOI":"10.1016\/j.schres.2003.07.003","type":"journal-article","created":{"date-parts":[[2003,11,15]],"date-time":"2003-11-15T13:16:36Z","timestamp":1068902196000},"page":"183-186","source":"Crossref","is-referenced-by-count":19,"title":["Secretin in a patient with treatment-resistant schizophrenia and prominent autistic features"],"prefix":"10.1016","volume":"66","author":[{"given":"Sayed S.","family":"Alamy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.Fredrik","family":"Jarskog","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian B.","family":"Sheitman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey A.","family":"Lieberman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2003.07.003_BIB1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0893-133X(01)00225-1","article-title":"GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder","volume":"25","author":"Benes","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.schres.2003.07.003_BIB2","series-title":"Comprehensive Textbook of Psychiatry","first-page":"2277","article-title":"Pervasive developmental disorders","author":"Campbell","year":"1995"},{"key":"10.1016\/j.schres.2003.07.003_BIB3","series-title":"Comprehensive Textbook of Psychiatry","first-page":"889","article-title":"Schizophrenia: introduction and overview","author":"Carpenter","year":"1995"},{"key":"10.1016\/j.schres.2003.07.003_BIB4","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1023\/A:1005443119324","article-title":"Secretin and autism: a two part clinical investigation","volume":"30","author":"Chez","year":"2000","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.schres.2003.07.003_BIB5","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1073\/pnas.95.1.322","article-title":"The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity","volume":"95","author":"de Lecea","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.schres.2003.07.003_BIB6","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/syn.10002","article-title":"Altered levels of Bcl2 and p53 proteins in parietal cortex reflect deranged apoptotic regulation in autism","volume":"42","author":"Fatemi","year":"2001","journal-title":"Synapse"},{"key":"10.1016\/j.schres.2003.07.003_BIB7","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archpsyc.57.1.65","article-title":"Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia","volume":"57","author":"Glantz","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2003.07.003_BIB8","first-page":"54","article-title":"Schizophrenia: a biochemical disorder?","volume":"32","author":"Horrobin","year":"1980","journal-title":"Biomedicine"},{"key":"10.1016\/j.schres.2003.07.003_BIB9","first-page":"9","article-title":"Improved social and language skills after secretin administration in patients with autistic spectrum disorders","volume":"9","author":"Horvath","year":"1998","journal-title":"J. Assoc. Acad. Minor. Physicians"},{"key":"10.1016\/j.schres.2003.07.003_BIB10","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0006-3223(00)00988-4","article-title":"Cortical Bcl-2 protein expression and apoptotic regulation in schizophrenia","volume":"48","author":"Jarskog","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2003.07.003_BIB11","first-page":"217","article-title":"Autistic disturbances of affective contact","volume":"2","author":"Kanner","year":"1943","journal-title":"Nerv. Child."},{"key":"10.1016\/j.schres.2003.07.003_BIB12","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/00005072-199807000-00001","article-title":"Neuropathology of infantile autism","volume":"57","author":"Kemper","year":"1998","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.schres.2003.07.003_BIB13","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1023\/A:1015441428154","article-title":"Efficacy of porcine secretin in children with autism and pervasive developmental disorder","volume":"32","author":"Kern","year":"2002","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.schres.2003.07.003_BIB14","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0896-6273(00)00115-X","article-title":"Autism spectrum disorders","volume":"28","author":"Lord","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.schres.2003.07.003_BIB15","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0006-3223(99)00018-9","article-title":"MRI anatomy of schizophrenia","volume":"45","author":"McCarley","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2003.07.003_BIB16","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1006\/bbrc.2002.6640","article-title":"In vitro autoradiographic localization of 125I-secretin receptor binding sites in rat brain","volume":"292","author":"Nozaki","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.schres.2003.07.003_BIB17","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1176\/ajp.152.8.1145","article-title":"An MRI study of brain size in autism","volume":"152","author":"Piven","year":"1995","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2003.07.003_BIB18","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s004010050401","article-title":"Hippocampus in autism: a Golgi analysis","volume":"91","author":"Raymond","year":"1996","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.schres.2003.07.003_BIB19","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1176\/ajp.143.7.862","article-title":"Lower Purkinje cell counts in the cerebella of four autistic subjects: initial findings of the UCLA-NSAC autopsy research report","volume":"143","author":"Rivto","year":"1986","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2003.07.003_BIB20","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJM199912093412404","article-title":"Lack of benefit of a single dose of synthetic human secretin in the treatment of autism and pervasive developmental disorder","volume":"341","author":"Sandler","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.schres.2003.07.003_BIB21","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1001\/archpsyc.1995.03950220015005","article-title":"Abnormally high neuronal density in the schizophrenic cortex: a morphometric analysis of prefrontal area 9 and occipital area 17","volume":"52","author":"Selemon","year":"1995","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2003.07.003_BIB22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0920-9964(03)00068-9","article-title":"Secretin for refractory schizophrenia","volume":"66","author":"Sheitman","year":"2003","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2003.07.003_BIB23","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1517\/14728222.6.2.175","article-title":"Biochemical aspects in autism spectrum disorders: updating the opioid-excess theory and presenting new opportunities for biomedical intervention","volume":"6","author":"Whiteley","year":"2002","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.schres.2003.07.003_BIB24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-9964(98)00094-2","article-title":"Mapping grey matter changes in schizophrenia","volume":"35","author":"Wright","year":"1999","journal-title":"Schizophr. Res."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092099640300241X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092099640300241X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,17]],"date-time":"2019-02-17T01:55:17Z","timestamp":1550368517000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092099640300241X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":24,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2004,2]]}},"alternative-id":["S092099640300241X"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2003.07.003","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2004,2]]}}}